About Microbot Medical Inc.
https://www.microbotmedical.comMicrobot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space.
CEO
Harel Gadot
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2018-09-05 | Reverse | 1:15 |
| 2016-11-29 | Reverse | 1:9 |
ETFs Holding This Stock
Summary
Showing Top 3 of 14
Ratings Snapshot
Rating : C+
Most Recent Analyst Grades
Grade Summary
Showing Top 1 of 1
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:2.34M
Value:$5.06M
CIBC PRIVATE WEALTH GROUP, LLC
Shares:1.45M
Value:$3.14M
SUSQUEHANNA INTERNATIONAL GROUP, LLP
Shares:1.25M
Value:$2.7M
Summary
Showing Top 3 of 73
About Microbot Medical Inc.
https://www.microbotmedical.comMicrobot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $0 | $3.85M ▲ | $-3.58M ▼ | 0% | $-0.07 ▲ | $-3.57M ▼ |
| Q2-2025 | $0 | $3.71M ▲ | $-3.5M ▼ | 0% | $-0.1 ▼ | $-3.49M ▼ |
| Q1-2025 | $0 | $3.02M ▼ | $-2.6M ▲ | 0% | $0.01 ▲ | $-3.01M ▲ |
| Q4-2024 | $0 | $3.4M ▲ | $-3.39M ▼ | 0% | $-0.2 | $-3.37M ▼ |
| Q3-2024 | $0 | $3.3M | $-3.21M | 0% | $-0.2 | $-3.28M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $80.16M ▲ | $81.76M ▲ | $3.54M ▲ | $78.22M ▲ |
| Q2-2025 | $32.67M ▲ | $33.13M ▲ | $2.77M ▲ | $30.36M ▲ |
| Q1-2025 | $30.39M ▲ | $30.89M ▲ | $1.94M ▼ | $28.95M ▲ |
| Q4-2024 | $5.47M ▲ | $6.03M ▲ | $2.5M ▲ | $3.53M ▼ |
| Q3-2024 | $4.34M | $5.21M | $1.4M | $3.81M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-3.58M ▼ | $-3.84M ▼ | $-44.71M ▼ | $51.18M ▲ | $2.62M ▲ | $-3.85M ▼ |
| Q2-2025 | $-3.5M ▼ | $-2.57M ▲ | $-1.31M ▲ | $4.75M ▼ | $870K ▲ | $-2.58M ▲ |
| Q1-2025 | $-2.6M ▲ | $-2.87M ▼ | $-24.83M ▼ | $27.81M ▲ | $102K ▼ | $-2.89M ▼ |
| Q4-2024 | $-3.39M ▼ | $-1.69M ▲ | $1.5M ▲ | $2.83M ▲ | $2.64M ▲ | $-1.7M ▲ |
| Q3-2024 | $-3.21M | $-2.76M | $140K | $633K | $-1.99M | $-2.76M |
CEO
Harel Gadot
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2018-09-05 | Reverse | 1:15 |
| 2016-11-29 | Reverse | 1:9 |
ETFs Holding This Stock
Summary
Showing Top 3 of 14
Ratings Snapshot
Rating : C+
Most Recent Analyst Grades
Grade Summary
Showing Top 1 of 1
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:2.34M
Value:$5.06M
CIBC PRIVATE WEALTH GROUP, LLC
Shares:1.45M
Value:$3.14M
SUSQUEHANNA INTERNATIONAL GROUP, LLP
Shares:1.25M
Value:$2.7M
Summary
Showing Top 3 of 73